News Posts List
POC Clinical Program of a New Anti-Tumor Drug Candidate MBC-11 Targeting Metastatic Bone Disease Read more: Maxwell Biotech Venture Fund Invests in POC Clinical Program of a New Anti-Tumor Drug Candi
09/26/2012
In early September the investment committee of Maxwell Biotech Venture Fund (âMBVFâ), founded with the participation of the Russian Governmentâs RVC, approved the binding terms and the amount of an investment in a newly established private Russian biotech company, Osteros Biomedica, Ltd, formed for the development and commercialization of drugs for the treatment of cancer-induced bone disease.
Bristol-Myers Squibb And The Promise Of Cancer Immunotherapy
09/26/2012
The majority of the responses seen with BMS-936558 lasted longer than one year. In addition, these anti-PD-1 antibodies managed to shrink away large metastatic tumors like lung and kidney, which are typically pretty resistant to therapy.
Did you know that general health could be affected by Oral health?
09/24/2012
48% more likely to develop kidney cancer due to poor oral health
Oral Health and Cancer Risk
09/24/2012
48% greater risk of kidney cancer seen among those with gum disease.
MD Anderson Moon Shots To Help Put An End To Cancer
09/24/2012
The center is launching its Moon Shots ProgramÂÂ as a way to rally up researchers, and put an end to cancer.
Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer
09/23/2012
This phase II trial is studying how well sunitinib works as first-line therapy in treating patients with locally advanced or metastatic papillary renal cell (kidney) cancer.
With patient welfare pitted against corporate social irresponsibility, lives are at stake
09/23/2012
The Supreme Court is hearing a case which could well determine whether patients grappling with deadly diseases can have access to affordable generic medicines.
Kidney Cancer Association Launches International Kidney Cancer Congress
09/22/2012
"We invite kidney cancer advocates from around the world to join us for this inaugural event..."
Charity Launches International Kidney Cancer Congress
09/22/2012
âWeâre pleased to announce the formation of an international collaboration of cancer patient organizations aimed at speeding innovative treatments from the bench to the bedside,â says Bill Bro, CEO of the Kidney Cancer Association (KCA), the worldâs largest charity dedicated to the eradication of death and suffering from renal cancers.
Occupational trichloroethylene exposure and kidney cancer risk: a meta-analysis
09/22/2012
Inconsistent epidemiological findings, debate over interpretation, and extrapolation of findings from animal studies to humans have produced uncertainty surrounding the carcinogenicity of trichloroethylene (TCE) exposure in occupational settings.
News Feed